Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare
Anika Therapeutics Inc. Revenue 2009–2025
Anika Therapeutics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Anika Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 29.6 M, a 13.16% increase year-over-year.
- Anika Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 111.8 M, a 14.49% decrease year-over-year.
- Anika Therapeutics Inc. annual revenue for 2025 was 112.8 M, a 5.91% decrease from 2024.
- Anika Therapeutics Inc. annual revenue for 2024 was 119.9 M, a 0.73% decrease from 2023.
- Anika Therapeutics Inc. annual revenue for 2023 was 120.8 M, a 6.12% increase from 2022.
- Anika Therapeutics Inc. annual revenue for 2022 was 113.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Anika Therapeutics Inc. Market Cap — FAQ
Anika Therapeutics Inc. (ANIK) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIK's market cap history?
The chart and table above show Anika Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.